��������

Thomas W. Burns has served as a member of our board of directors since September 2020. Since March 2002, Mr. Burns has served the President, Chief Executive Officer and a member of the board of directors of Glaukos Corporation, a medical technology and pharmaceutical company. From October 2009 until June 2015, Mr. Burns served as a member and the chairman of the board of directors of DOSE Medical Corporation, a medical technology company. From March 2010 until June 2015, Mr. Burns served as DOSE Medical Corporation’s Chief Executive Officer and President. From July 2018 until August 2019, Mr. Burns served on the board of directors of Avedro, Inc., prior to its acquisition by Glaukos. Mr. Burns holds a B.A. from Yale University. We believe that Mr. Burns is qualified to serve as a member of our board of directors because of his extensive leadership and management experience in the medical technology industry and his experience on private and public company boards.